Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
31
RBGLY Quote, Financials, Valuation and Earnings
Last price:
$12.03
Seasonality move
:
0.16%
Day range:
$11.96 - $12.14
52-week range:
$10.24 - $15.03
Dividend yield:
4.2%
P/E ratio:
22.07x
P/S ratio:
2.39x
P/B ratio:
4.06x
Volume:
354.6K
Avg. volume:
452.6K
1-year change:
-11.74%
Market cap:
$41.4B
Revenue:
$18.2B
EPS (TTM):
$0.55
Analysts' Opinion
-
Consensus RatingReckitt Benckiser Group PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Reckitt Benckiser Group PLC has an estimated downside of -- from its current price of $12.03.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $12.03.
Fair Value
-
According to the consensus of 0 analysts, Reckitt Benckiser Group PLC has -- downside to fair value with a price target of -- per share.
RBGLY vs. S&P 500
-
Over the past 5 trading days, Reckitt Benckiser Group PLC has overperformed the S&P 500 by 0.11% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Reckitt Benckiser Group PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Reckitt Benckiser Group PLC has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Reckitt Benckiser Group PLC reported revenues of --.
Earnings Growth
-
Reckitt Benckiser Group PLC has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Reckitt Benckiser Group PLC reported earnings per share of --.
Enterprise value:
51B
EV / Invested capital:
--
Price / LTM sales:
2.39x
EV / EBIT:
15.57x
EV / Revenue:
2.84x
PEG ratio (5yr expected):
--
EV / Free cash flow:
18.74x
Price / Operating cash flow:
13.65x
Enterprise value / EBITDA:
13.19x
Gross Profit (TTM):
$10.9B
Return On Assets:
5.67%
Net Income Margin (TTM):
10.82%
Return On Equity:
17.83%
Return On Invested Capital:
9.03%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2010-12-31 | 2011-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $3.6B | $3.8B | |
| Gross Profit | -- | -- | -- | $2.2B | $2B | |
| Operating Income | -- | -- | -- | $1.1B | $1.2B | |
| EBITDA | -- | -- | -- | $958.8M | $1.1B | |
| Diluted EPS | -- | -- | -- | $0.18 | $0.22 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.6B | $9.4B | $6.7B | $6.3B | $6.2B | |
| Total Assets | $42.4B | $38.4B | $35.2B | $34.7B | $33.4B | |
| Current Liabilities | $9.2B | $13B | $9.6B | $11.7B | $8.9B | |
| Total Liabilities | $30B | $29.3B | $24.3B | $23.1B | $23.2B | |
| Total Equity | $12.3B | $9.1B | $10.9B | $11.6B | $10.2B | |
| Total Debt | $15.3B | $14.2B | $11.4B | $10.5B | $10.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2010-12-31 | 2011-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $2.4B | $2.8B | |
| Cash From Investing | -- | -- | -- | -$4.3B | -$1B | |
| Cash From Financing | -- | -- | -- | $2.3B | -$1.6B | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RBGLY
Sector
Market Cap
$41.4B
$348.1M
Price % of 52-Week High
80.04%
73.74%
Dividend Yield
4.2%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
-11.74%
-12.75%
Beta (5-Year)
0.440
0.504
Dividend yield:
4.2%
Annualized payout:
$0.46
Payout ratio:
35.14%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$12.20
200-day SMA
Buy
Level
$11.63
Bollinger Bands (100)
Buy
Level
11.4 - 12.56
Chaikin Money Flow
Buy
Level
96.6M
20-day SMA
Sell
Level
$12.24
Relative Strength Index (RSI14)
Sell
Level
42.71
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-84.0909
50-day SMA
Sell
Level
$12.32
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
20.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.1572)
Sell
CA Score
(Annual)
Level (-0.6501)
Buy
Beneish M-Score
(Annual)
Level (-2.6358)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.4429)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
Stock Forecast FAQ
In the current month, RBGLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RBGLY average analyst price target in the past 3 months is --.
-
Where Will Reckitt Benckiser Group PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Reckitt Benckiser Group PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Reckitt Benckiser Group PLC?
Analysts are divided on their view about Reckitt Benckiser Group PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Reckitt Benckiser Group PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is Reckitt Benckiser Group PLC's Price Target?
The price target for Reckitt Benckiser Group PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RBGLY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Reckitt Benckiser Group PLC is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of RBGLY?
You can purchase shares of Reckitt Benckiser Group PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Reckitt Benckiser Group PLC shares.
-
What Is The Reckitt Benckiser Group PLC Share Price Today?
Reckitt Benckiser Group PLC was last trading at $12.03 per share. This represents the most recent stock quote for Reckitt Benckiser Group PLC. Yesterday, Reckitt Benckiser Group PLC closed at $12.03 per share.
-
How To Buy Reckitt Benckiser Group PLC Stock Online?
In order to purchase Reckitt Benckiser Group PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
